5AM Venture Management, LLC
SAN FRANCISCO, CA · CIK 1799883 · 13F filing filed 2023-08-14
SEC-registered investment adviser since 2021 · limited liability company
- Assets managed$1.1bn
- Staff32 · 18 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds12 (1 hedge) · $947.0m gross assets
- Website5amventures.com
- Form ADV · 2026-03-30SEC adviser record
- Kindhedge funds, private equity, venture, futures
- Others nearbySan Francisco, CA, Boston, MA, New York, NY
As an employer
- Offices in1 country
- Private fundsventure capital 9, private equity 2, hedge 1
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| San Francisco, CA (main office)United States | about 8 |
| Boston, MAUnited States | 7 |
| New York, NYUnited States | 3 |
US visa salary filings
- Filings FY20251
- Median salary offered$350,000
- Middle half$350,000 – $350,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Senior Research AnalystNew York, NY | 1 | $350,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: 5AM Venture Management, LLC.
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ENLIVEN THERAPEUTICS INC ELVN | $118.3m29.48% | Unchanged |
| ENTRADA THERAPEUTICS INC TRDA | $66.7m16.63% | Unchanged |
| DISC MEDICINE INC IRON | $21.7m5.40% | Reduced -100.0k |
| RALLYBIO CORP COM | $20.5m5.12% | Unchanged |
| VOR BIOPHARMA INC COM | $19.7m4.90% | Unchanged |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $18.2m4.54% | Added +318.6k |
| CRINETICS PHARMACEUTICALS IN CRNX | $15.5m3.87% | Unchanged |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $13.8m3.44% | New |
| SCPHARMACEUTICALS INC SCPH | $12.2m3.05% | Unchanged |
| CELLDEX THERAPEUTICS INC NEW CLDX | $10.5m2.62% | New |
| VIKING THERAPEUTICS INC VKTX | $9.5m2.36% | Added +235.0k |
| COGENT BIOSCIENCES INC COGT | $9.4m2.33% | Unchanged |
| PHARVARIS N V PHVS | $8.9m2.22% | Unchanged |
| ARVINAS INC ARVN | $7.9m1.98% | Unchanged |
| AVIDITY BIOSCIENCES INC RNA | $7.4m1.84% | Unchanged |
| ANAPTYSBIO INC ANAB | $7.3m1.81% | Unchanged |
| MIRATI THERAPEUTICS INC MRTX | $7.0m1.73% | New |
| VIRIDIAN THERAPEUTICS INC VRDN | $6.7m1.66% | Unchanged |
| SPRUCE BIOSCIENCES INC COM | $5.1m1.27% | Unchanged |
| MERSANA THERAPEUTICS INC COM | $4.3m1.07% | Added +120.0k |
| HOMOLOGY MEDICINES INC FIXX | $4.0m1.00% | Unchanged |
| IMPEL PHARMACEUTICALS INC COM | $3.7m0.91% | Unchanged |
| GH RESEARCH PLC GHRS | $1.8m0.45% | New |
| CIDARA THERAPEUTICS INC COM | $1.3m0.32% | Unchanged |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| IDEAYA BIOSCIENCES INC IDYA | $11.9m868.5k shares |
| FIBROGEN INC | $10.8m579.4k shares |
| IVERIC BIO INC OPHT | $6.9m284.6k shares |
| PEAR THERAPEUTICS INC | $4.3m16.7m shares |